ASCO 2023
ASCO 2023
Advertisement
Rob DillardASCO 2023 | May 31, 2023
US veterans who were exposed to Agent Orange have an increased risk of myeloproliferative neoplasms.
Read More
Rob DillardASCO 2023 | May 31, 2023
The novel JAK1-sparing inhibitor pacritinib is effective at reducing spleen enlargement and disease burden in MF patients.
Rob DillardASCO 2023 | May 31, 2023
The safety and efficacy of luspatercept is favorable for treating anemia in patients with myelofibrosis.
Rob DillardASCO 2023 | May 31, 2023
Patients admitted for atrial fibrillation who have myeloproliferative neoplasms have an increased risk of bleeding.
Rob DillardASCO 2023 | May 26, 2023
Extending colorectal cancer screening to older populations using stool testing results in more life years gained.
Rob DillardASCO 2023 | May 25, 2023
People with a history of skin cancer lack sufficient knowledge on photoprotection, study finds.
Advertisement
Advertisement
Advertisement
Latest News

June 2, 2023